Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells ☆

Abstract Calcineurin (CN) is thought to play an important role in the immune system by regulating cytokine production, for example, interleukin-2 (IL-2) in T-lymphocytes. We have previously shown that physiological concentrations of Zn 2+ inhibit CN activity in vitro [K. Takahashi, E. Akaishi, Y. Abe, R. Ishikawa, S. Tanaka, K. Hosaka, Y. Kubohara, Zinc inhibits calcineurin activity in vitro by competing with nickel, Biochem. Biophys. Res. Commun. 307 (2003) 64–68], in spite of the fact that Zn 2+ is an essential element of the CN catalytic domain. In this study, in order to assess whether Zn 2+ regulates (suppresses) CN activity in vivo and whether Zn 2+ can be used as an anti-inflammatory and/or immunosuppressive drug, we examined the effects of Zn 2+ on IL-2 production induced by the mitogen, concanavalin A (ConA), in Jurkat T-cells. Zn 2+ at 0.2 mM suppressed ConA-induced IL-2 accumulation in the medium of an in vitro culture of Jurkat cells. Zn 2+ at 0.03–0.3 mM dose-dependently suppressed ConA-induced IL-2 mRNA expression in Jurkat cells. Zn 2+ also suppressed IL-2 mRNA expression induced by phorbol ester (PMA) and ionomycin. Furthermore, Zn 2+ and the immunosuppressant FK506 showed an additive inhibitory effect on ConA-induced IL-2 mRNA expression. These results suggest that exogenously added Zn 2+ may disturb (increase) the intracellular Zn 2+ concentration and inhibit CN activity, thereby suppressing IL-2 production in Jurkat cells. The present study further indicates that Zn 2+ may have therapeutic potential in the treatment of T-cell related inflammation and also that Zn 2+ may be utilized as a supplemental drug with FK506.